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Background: An international discussion about whether or not to legally permit euthanasia and (or) physician
assisted suicide (EAS) is ongoing. Unbearable suffering in patients may result in a request for EAS. In the Netherlands EAS
is legally permitted, and unbearable suffering is one of the central compulsory criteria. The majority of EAS is performed in
cancer patients in the primary care practice. In around one in every seven end-of-life cancer patients dying in the primary
care setting EAS is performed. The prevalence of unbearable symptoms and overall unbearable suffering in relationship to
explicit requests for EAS was studied in a cohort of end-of-life cancer patients in primary care.
Methods: A prospective study in primary care cancer patients estimated to die within six months was performed. Every
two months suffering was assessed with the State-of-Suffering V (SOS-V). The SOS-V is a comprehensive instrument for
quantitative and qualitative assessment of unbearable suffering related to 69 physical, psychological and social symptoms
in five domains.
Results: Out of 148 patients who were asked to participate 76 (51%) entered the study. The studied population were 64
patients who were followed up until death; 27% explicitly requested EAS, which was performed in 8% of the patients. The
final interview per patient was analyzed; in four patients the SOS-V was missing. Unbearable symptoms were present in
94% of patients with an explicit request for EAS and in 87% of patients without an explicit request. No differences were
found in the prevalence of unbearable suffering for physical, psychological, social and existential symptoms, nor for overall
unbearable suffering, between patients who did or who did not explicitly request EAS.
Conclusions: In a population of end-of-life cancer patients cared for in primary care no differences in unbearable
suffering were found between patients with and without explicit requests for EAS. The study raises the question whether
unbearable suffering is the dominant motive to request for EAS. Most patients suffered from unbearable symptoms,
indicating that the compulsory criterion of unbearable suffering may be met a priori in most end-of-life cancer patients
dying at home, whether they request EAS or not.Background
Unbearable suffering is considered an important motive
for patients requesting euthanasia and/or assisted suicide
(EAS) [1]. Seven countries and states have legalized
EAS, or permit EAS under existing law [2]. The pres-
ence of unbearable suffering, as assessed by a physician,
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teria to legally allow EAS include a voluntary and well
considered request for EAS, prospect-less suffering, ab-
sence of reasonable treatment options and consultation
with an independent physician [6,7]. Terminal illness is
not a compulsory criterion [6]. The legal model which ap-
plies in Switzerland, Oregon, Washington and Montana
requires a voluntary and well considered request; unbear-
able suffering is not a compulsory criterion and only
assisted suicide is allowed [2,8,9]. Terminal illness is a
compulsory criterion in the U.S. states [2].
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die at home [10]. Primary care nationwide is provided by
nearly 9.000 general practitioners (GPs), 57% of whom
work part time [11]. A full time GP on average provides
end-of-life care for a cancer patient nearly three times a
year [12].
Performed euthanasia in the Netherlands has been
studied in 5-year intervals since 1990 [13,14]. In 2002
EAS was legalized. By 2005 the total number of explicit
requests for EAS was 8400; 29% of all explicit requests
for EAS were granted; 1.8% of all deaths were the result
of EAS (n = 2410) [14,15]. In 2010 the total number of
explicit requests for EAS was 9100; 45% of all explicit re-
quests for EAS were granted; 2.8% of all deaths were the
result of EAS (n = 4050) [13,16]. In the 2010 study 79% of
all EAS patients has a cancer diagnosis. Eighty-eight per-
cent of EAS cases were performed in primary care [13].
In end-of-life cancer patients dying in the primary care
setting EAS is performed in around one in every seven
patients [17]. EAS most frequently is performed in the
estimated last two weeks of life [13]. Legal responsibility
for EAS allotted to the medical profession changes the
dynamics of interaction between patients and physicians
[18]. Doctors face difficulties in assessing and respond-
ing to suffering and requests for EAS [1,3,19-23]. Patient
directed research investigating unbearable suffering in
relationship to whether an explicit request for EAS is
made is scarce. In this study the presence and nature of




The study was conducted in Utrecht, a city with about
235 000 people and 105 GPs. Those eligible for the study
were terminal cancer patients expected to die within half
a year and who were expected to live at home (most of
the time) until death. They were cared for by a GP as
the primary responsible physician. The GPs estimated
survival, and clinical deterioration guided estimation of
survival.
Forty-four GPs, representing 42% of the GPs in the
city, 59% of whom worked part time, requested partici-
pation from eligible patients. A study coordinator orga-
nized the recruitment process, which included identifying
all eligible patients in the care of GPs during the follow-up
period. Baseline-characteristics of all eligible patients were
registered. Within a week the baseline interview was ad-
ministered to consenting patients. Follow-up interviews
were administered every two months, or sooner based
upon information by GPs that the condition of a patient
had rapidly deteriorated. All interviews were at the pa-
tients’ residence. GPs were personally contacted every two
months for follow-up data. When a patient died thetreating physician was asked whether an explicit request
for EAS had been made; a record of the date of the
request was not part of the study design. Whether EAS
actually was performed was not part of the initial
physician-directed follow-up, because of the potential
negative influence on recruitment related to enquiring
about this sensitive subject. Transition to a hospice was
not an exclusion criterion; in many Dutch hospices the
GP remains responsible for palliative care. The inter-
viewers were a physiotherapist (the study coordinator)
and a GP (CR), both trained in interview techniques.
The study protocol was approved by the Medical Ethics
Committee at the VU University. Written informed con-
sent was obtained from participants. The recruitment
process is described in detail elsewhere [24].
Patient recruitment occurred from May 2003 until
May 2006, follow-up continued until May 2007. There
were 258 eligible patients. One hundred and ten patients
were not requested to participate, in majority because
their physical condition deteriorated so rapidly that their
GP considered an interview too burdensome. Seventy-
six out of 148 invited patients (51%) entered the inter-
view study. Seventy-two patients refused to participate,
in majority because of rapidly deteriorating physical con-
dition and considering the interview too burdensome. In
the 76 patients who entered the interview study the
attrition rate was 8% (n = 6), caused by patients who
stopped participating after one or more interviews. At
the end of follow-up period 8% (n = 6) of the patients
were alive, leaving 64 patients with follow up until death.
In 60 patients at least one SOS-V interview was present;
in four patients the interview was missing; the inter-
viewer had considered the interview too burdensome
and abandoned. In 33 patients the SOS-V was adminis-
tered at least two times. Age, gender and type of cancer
did not differ between the patients in and out of the
interview sample. In January 2014 the GPs who had
been addressed with a request for EAS were personally
contacted to assess whether EAS had been performed.
All GPs agreed to share this important information.
Medical files were checked and dying trajectories were
evaluated.
Issues concerning the investigation of unbearable
suffering
Unbearable suffering was defined as a subjective experi-
ence of suffering that is so serious and uncontrollable
that it overwhelms one’s bearing capacity [25]. Unbear-
able suffering is a relative experience, which may be more
or less present. Quantitative investigation of unbearable suf-
fering provides the opportunity to compare patient popula-
tions. The measure of unbearable suffering needs to be
differentiated from the intensity of symptoms; symptoms
may be intensely present yet bearable, and vice versa [17].
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specific disease indicates a systematic investigation of
whether disease specific symptoms are present [26-29],
followed by an assessment of whether symptom related
unbearable suffering occurs. Suffering caused by co-
morbidities, particularly if these result in unbearable suf-
fering, may confound study outcomes and needs to be
assessed. Investigation of the various physiological sys-
tems whether symptoms caused by co-morbidity occur
and whether these symptoms result in unbearable suffer-
ing is indicated. Suffering reaches further than biomedical
symptoms, it includes the consequences and meaning of
disease for the various domains of life. These domains in-
clude practical daily functioning (functional domain), the
perspective of self (personal domain), functioning in rela-
tionship to others (domain of social environment) and
perspective of the future (domain of future perspective).
Suffering in these domains, related to disease as well as in-
dependent of disease, adds to suffering and needs to be in-
vestigated [30,31]. The meaning of suffering [21,30-36]
cannot be fully understood by a study limited to providing
scores. Assessment about the personal experience of the
suffering is necessary.
A framework of categories of suffering may help to
organize qualitative study outcomes of experiences of
suffering. The qualitative descriptions may be attributed
to a framework of biomedical, psychodynamic and emo-
tional categories of suffering. An important psycho-
dynamic perspective of suffering is the concept of loss,
such as loss of meaning, loss of autonomy, loss of dig-
nity or loss of hope [21,31,33,34,36,37]. Emotional cate-
gorizations of suffering include depression, hopelessness,
demoralization, anxiety, worrying and feeling tensed
[31,38-40]. Suffering is complex and there is no univer-
sal, clear-cut, comprehensive system of categorization of
suffering [31,41]. The frequently employed categorization
in physical, psychological, social and existential suffering
[32,42-45] demonstrates overlap. This categorization may
suggest that existential suffering is a separate entity. How-
ever, physical, psychological and social suffering may re-
sult in existential suffering, and existential suffering may
be part of various categories of suffering [46]. For the pur-
pose of analysis of qualitative data about suffering a con-
sidered choice may be made for categories relevant to the
study perspective.
Measurement instrument: the State-of-Suffering V
To realize this study the State-of-Suffering V (SOS-V)
was developed. The SOS-V is a structured, quantitative
instrument for comprehensive assessment of unbearable
suffering related to symptoms, with additional open
ended questions to investigate the experience of suffer-
ing [17,25]. “Symptoms” refers to physical, psychological,
social and existential aspects of suffering; this extendedinterpretation of symptoms is not uncommon in psycho-
somatic research. Cancer is polysymptomatic [26] and
systematic assessment of symptoms is indicated [27].
Based upon literature study a framework of domains in
which suffering may occur was selected and symptoms
relevant to end-of-life cancer populations were intro-
duced. The SOS-V systematically addresses 69 symptoms
in a framework of five domains: (I) medical symptoms;
(II) loss of function; (III) personal aspects; (IV) environ-
ment and; (V) nature and prognosis of disease [25]. For
every symptom two questions are asked. First, what is
the intensity (or extent) of the symptom? Second, if the
symptom is present, to what extent does the symptom
cause unbearable suffering?
A uniform 5-point scoring scale with a description is
employed for both questions: 1-not at all; 2-slightly; 3-
moderately; 4-seriously; 5-very seriously, hardly could be
worse. When a patient rates 4 or 5 for unbearable suffer-
ing, the experience is further explored through open
ended questions. Answers are immediately written down
as quoted phrases. After rating all 69 symptoms the
interviewer asks whether individual aspects of suffering
are missing, and if so documents and rates these as well.
Reduction of symptoms investigated with the SOS-V
was not striven for; suffering is multidimensional, the
symptoms are clinically differentiable and it requires con-
sideration that even one symptom may determine unbea-
rability. The total number of symptoms which cause
suffering does not automatically add up to an overall ex-
perience of suffering. The overall experience of suffering is
assessed at the end of the interview; the patient is asked to
consider all present symptoms and rate overall unbearable
suffering (same scale). The two days before the interview
were the reference period for assessment of suffering. The
development of the instrument is described elsewhere
[25]. Administration of the quantitative section of the SOS-
V generally was possible within 15 to 20 minutes [12,25].
Analysis
Only the final SOS-V interviews were analyzed as they
were the interviews closest to death, taking in account
that performing EAS in response to an explicit request
in majority occurs in the final two weeks of life [13,16].
The question about the intensity of symptoms was di-
chotomized into the symptom not at all being present
(rating 1) versus the symptom being present (ratings 2–
5). When a symptom was not at all present, it was as-
sumed that the symptom did not lead to unbearable
suffering, and a rating of 1 was given for unbearable suf-
fering. After that the quantitative data about unbearable
suffering were analyzed dichotomously. Ratings 1 (not at
all), 2 (slightly) or 3 (moderately) for suffering were
defined as bearable; ratings 4 (seriously) or 5 (very ser-
iously, hardly could be worse) were defined as unbearable.
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overall unbearable suffering between patients who did
and who did not request EAS were tested with a Fisher’s
exact test for nominal variables and with a t-test for
continuous variables; the p-level was 0,05. Additionally
Bonferroni analysis for high numbers of independent
tests was applied.
To organize the qualitative descriptions of the experi-
ences of suffering, related to symptoms for which the pa-
tients rated 4 or 5 for unbearable suffering, a categorization
schedule was composed of senses of suffering which are
relevant in patients at the end of life (Table 1) [17]. Existen-
tial suffering, an important construct of suffering, was not
separately identified, from the perspective that other identi-
fiable senses of suffering all may potentially contribute to
existential suffering [21,26-30,32-36,38,41-43,46-48]. Two
raters, a GP (CR) and an external clinical psychologist,
independently rated the descriptions of the experiences of
unbearable suffering according to the categorization sche-
dule. One rating per unbearable description was permitted.
The raters then deliberated about the ratings which wereTable 1 Categorization of qualitative data
Category of
suffering
Indications for assigning category
Physical Medical morbidity, the physical symptom itself, physi
which result in physical experienced suffering
Loss of meaning Loss of: identity, capacity of self-fulfillment, communi
role, social interaction, intimacy
Loss of autonomy Suffering acknowledged to be caused by loss of auto
functioning and occurrence of dependency (presenc
autonomy is not sufficient for assigning)
Loss of dignity Socially embarrassing symptoms, shame, body image
taken seriously, worthlessness
Burden to others Experience to be a burden to others
Loss of sexual role Loss of capability of sexual functioning; loss of sexual
Fear of future
suffering
Fear caused by awareness of possible suffering relate
of disease
Anxiety Anxiety
Death anxiety Anxiety related to awareness of the process of dying
come along with that, and anxiety related to the actua
Depressiveness Suffering caused by the presence of depressive thoug
Worrying Negative thoughts which cannot be turned off
Feeling tensed Feeling tensed in mind or body
Hopelessness Loss of possibility of meaning
Pointlessness Total loss of meaning; nothing leftnot identically attributed and provided identical rating, if
possible, after discussion. Only identically attributed ratings
were used to analyze differences between patients who did
and who did not request EAS. Consensus between the
raters occurred in 86% of the analyzed qualitative descrip-
tions. T-test for mean prevalence were used for statistical
analysis. The rating process is described in more detail else-
where [17].
Results
The studied sample consisted of the 64 patients who died
during follow-up; 46 patients died within six months after
inclusion. The average age was 70 years (range 38–86),
52% were female, all patients were Caucasian. Lung cancer
(27%) and gastro-intestinal cancer (25%) were most preva-
lent. An explicit request for EAS occurred in 27% (17 pa-
tients); EAS was performed in 8% (5 patients). A part of
the study design was to obtain information from GPs that
the condition of a patient had rapidly deteriorated, so that
additional interviews could be planned close to death.
This rarely occurred. The final interview was on averageExample of categorization
cal symptoms Pain: I have pain all day, it occupies me continuously,
there is little distraction
cation, social Impaired working capacity: I miss the contact with
people. The only one left is my wife
nomous
e itself of loss of
Trouble accepting present situation: The dependency on
other people
concerns, not Impaired comprehension of speech: I feel stupid, I can’t
come along
Feeling to be a burden to others: I feel troubled to ask
other people for help
role Restricted sexuality: my sexual life is destroyed, it is
gone, not only for me, but also for my wife
d to progress Fear to lose the strength to bear the suffering: Pain, I
have fear for pain
Not sleeping well: I have these nightmares, it wakens
me up and makes me frightened
and what may
l dying process
Fear of future suffering: I am afraid to suffocate
hts Feel depressed: It is an annoying feeling. It is also
influenced by the situation of my daughters: they are
not doing well
Impaired coordination of movements: I am afraid to fall,
I hold on to everything
Feel tensed: Especially in bed; each time again I feel
tense and keep saying “relax”
Hopelessness: To say farewell is what makes me feel
hopeless
General discomfort: Not being able to do a thing, just
waiting for death
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was administered within two weeks prior to death. An ad-
vance euthanasia directive (77% versus 9%) and higher
education (defined as any further education after high
school) (35% versus 13%) were significantly more frequent
in the group of patients with an explicit request; for the
other demographic characteristics no differences occurred
(Table 2). The prevalence of explicit requests for EAS was
15% (16 out of 110 patients) in the sample which was not
invited to participate, and 10% (7 out of 72 patients) in the
sample which declined participation.
Unbearable symptoms were present in 88% (n = 53) of
the 60 patients studied with the SOS-V. No significant
differences in prevalence of unbearable symptoms oc-
curred between patients with and without an explicit re-
quest for EAS (Tables 3 and 4). “Needing help with
housekeeping” was unbearable more frequently in pa-
tients with an explicit request for euthanasia (65% versus
33%), however after application of the Bonferroni cor-
rection no significant differences remained. No differ-
ences occurred between patients with and without an
explicit EAS request for mean total of unbearable symp-
toms (mean 11.6 ± SD 8.6 unbearable symptoms versus
mean 10.3 ± SD 9.3 unbearable symptoms) and for
prevalence of overall unbearable suffering (33% versusTable 2 Patient characteristics for patients with and












Male 59(10) 45(21) 0.400
Partner status: single 53(9) 68(32) 0.265
Education 0.043
- Higher 35(6) 13(6)
- Middle or lower 65(11) 87(41)




Type of cancer 0.738
- Lung 35(6) 30(14)
- Colorectal 24(4) 15(7)
- Hematologic 6(1) 11(5)
- Urologic 12(2) 9(4)
- Breast 0(0) 9(4)
- Other 24(4) 28(13)
Rounded percentages and absolute numbers.
*Fisher’s exact test for all variables except age (t-test).
†one missing observation (in group ‘explicit request for euthanasia’).28%). Unbearable symptoms were present in 94% of pa-
tients with an explicit request for EAS and in 87% of
patients without an explicit request. There were no dif-
ferences in numbers of unbearable symptoms per
domain.
The qualitative analysis demonstrated no significant
differences in senses of unbearable suffering between
patients with and without an explicit request for eu-
thanasia (Table 5). Examples of attributions of qualita-
tive data to categories are additionally provided in
Table 1. Additional information about the trajectory of
patients with an explicit request for EAS is provided in
Table 6.
Two of the patients withdrew their request for EAS.
Reasons why EAS was not performed could not be re-
trieved from the medical files in the other patients.
No conflicts between patients and GPs about whether
or not to perform EAS were identified; in one case a
conflict with the family occurred because EAS was
not performed. Referral to other physicians, because
GPs did not agree with performing EAS, did not
occur.
Discussion
The present study touches on fundamental questions
about suffering, autonomy and the tasks of the medical
profession concerning life and death. We have not iden-
tified prior patient directed studies which prospectively
investigated unbearable suffering in relationship to re-
quests for EAS in a cohort of patients. EAS in one out
of three patients with an explicit request for euthanasia
is comparable to findings in other studies in the Dutch
setting [13,14,49,50].
No differences occurred in prevalence of unbearable
symptoms, or in prevalence of overall unbearable suf-
fering, between patients with and without an explicit
request for EAS. Frequently mentioned motives for
requesting EAS are loss of control, loss of autonomy,
loss of dignity, not wanting to be a burden to others and
fear of the future [8,32,51-55]. The prevalences of these
motives, from the perspective of unbearable suffering,
were not different for patients with and without a re-
quest for EAS. Loss of control, isolation, hopelessness,
burden on others and fear about the future, which in re-
search were found indicative of existential issues [46],
were not different for patients with and without unbear-
able suffering. These findings may indicate that unbear-
able suffering is not the dominant motive to request
EAS.
Unbearable symptoms occurred in 88% of this primary
care population of end-of-life cancer patients in the
period around one month before death. This indicates
that the criterion of unbearable suffering, also when not
being the decisive motive to request EAS, may be met in
Table 3 Symptom unbearability in the domain of medical symptoms in patients with and without an explicit request




EAS request (n = 17)
%(n)
No EAS request (n = 43)
%(n)
P-value All patients (n = 60)
% (n)*
Domain I: Medical symptoms
Weakness 93 (56) 71 (12) 51 (22) 0.249 57 (34)
General discomfort 80 (48) 35 (6) 37 (16) 0.995 37 (22)
Tiredness 87 (52) 47 (8) 30 (13) 0.243 35 (21)
Pain 72 (43) 29 (5) 23 (10) 0.743 25 (15)
Loss of appetite 62 (37) 18 (3) 28 (12) 0.520 25 (15)
Not sleeping well 47 (28) 29 (5) 23 (10) 0.743 25 (15)
Changed appearance 78 (47) 18 (3) 23 (10) 0.740 22 (13)
Vomiting 27 (16) 24 (4) 19 (8) 0.726 20 (12)
Shortness of breath 59 (35) 24 (4) 16 (7) 0.712 19 (11)
Impaired co-ordination 57 (34) 12 (2) 21 (9) 0.713 18 (11)
Loss of concentration 40 (24) 12 (2) 19 (8) 0.711 17 (10)
Memory loss 43 (26) 12 (2) 16 (7) 0.995 15 (9)
Incomprehensible speech 32 (19) 18 (3) 14 (6) 0.704 15 (9)
Nausea 28 (17) 12 (2) 14 (6) 0.725 13 (8)
Smelling unpleasant 35 (21) 18 (3) 12(5) 0.676 13 (8)
Impaired hearing 33 (20) 12 (2) 14 (6) 0.996 13 (8)
Thirst 45 (27) 18 (3) 9 (4) 0.399 12 (7)
Feeling tensed 44 (26) 24 (4) 7 (3) 0.090 12 (7)
Impaired mental clarity 42 (25) 12 (2) 12 (5) 0.995 12 (7)
Swallow food impaired 35 (21) 12 (2) 12 (5) 0.995 12 (7)
Feeling depressed 34 (20) 6 (1) 14 (6) 0.661 12 (7)
Constipation 30 (18) 18 (3) 9 (4) 0.393 12 (7)
Dizziness 27 (16) 0 (0) 16 (7) 0.175 12 (7)
Hiccups 22 (13) 18 (3) 7 (3) 0.338 10 (6)
Intestinal cramps 22 (13) 18 (3) 5 (2) 0.132 8 (5)
Impaired sight 42 (25) 12 (2) 5 (2) 0.317 7 (4)
Itch 32 (19) 12 (2) 5 (2) 0.317 7 (4)
Feeling anxious 27 (16) 6 (1) 7 (3) 0.997 7 (4)
Swallowing fluid impaired 23 (14) 12 (2) 5 (2) 0.317 7 (4)
Diarrhea 20 (12) 12 (2) 5 (2) 0.317 7 (4)
Incontinence of feces 8 (5) 6 (1) 7 (3) 0.997 7 (4)
Coughing 38 (23) 6 (1) 5 (2) 0.997 5 (3)
Pressure ulcers 8 (5) 12 (2) 0 (0) 0.996 3 (2)
Comprehension of speech impaired 7 (4) 0 (0) 5 (2) 0.998 3 (2)
Paralyzed limbs 5 (3) 0 (0) 2 (1) 0.999 2 (1)
Skin metastasis 3 (2) 0 (0) 2 (1) 0.999 2 (1)
Incontinence of urine 10 (6) 0 (0) 0 (0) 1.00 0 (0)
The SOS-V was missing in four patients.
Scoring: 1-not at all; 2-slightly ; 3-moderately; 4-seriously; 5-very seriously, hardly could be worse.
Suffering bearable: scores 1–3; Suffering unbearable: scores 4,5.
Rounded percentages and absolute numbers.
*Between 0 to 1 missing observations per symptom.
Fisher’s exact tests.
Ruijs et al. BMC Palliative Care 2014, 13:62 Page 6 of 11
http://www.biomedcentral.com/1472-684X/13/62
Table 4 Symptom unbearability in the domains of loss of function, personal aspects, environment, nature and
prognosis of disease in patients with and without an explicit request for euthanasia (n = 60; for patients with
administered SOS-V)*
Symptom present Symptom unbearable
EAS request No EAS request p-value** All patients






Domain II: Loss of function
Impaired routine daily activities 83 (50) 53 (9) 56 (24) 0.995 55 (33)
Impaired leisure activities 82 (49) 65 (11) 44 (19) 0.252 50 (30)
Help needed with housekeeping 71 (42) 65 (11) 33 (14) 0.040** 42 (25)
Bedridden 56 (33) 29 (5) 33 (14) 0.996 32 (19)
Help needed with self-care 60 (36) 35 (6) 16 (7) 0,192 22 (13)
Impaired working capacity 17 (10) 6 (1) 14 (6) 0.661 12 (7)
Impaired sexuality 14 (8) 0 (0) 7 (3) 0.551 5 (3)
Domain III: Personal aspects
Feeling dependent on others 80 (48) 47 (8) 44 (19) 0.995 45 (27)
Not able to do things you consider important 63 (36) 35 (6) 42 (18) 0.773 42 (24)
Trouble accepting the present situation 60 (36) 41 (7) 30 (13) 0.545 33 (20)
Loss of control over your own life 30 (18) 18 (3) 30 (13) 0.518 27 (16)
Negative thoughts or worrying 32 (19) 6 (1) 19 (8) 0.423 15 (9)
Feeling a nuisance to others 38 (23) 24 (4) 9 (4) 0.206 13 (8)
Hopelessness 28 (17) 24 (4) 9 (4) 0.206 13 (8)
Feeling not any longer being the same person 28 (17) 0 (0) 14 (6) 0.170 10 (6)
Feelings of worthlessness 22 (13) 12 (2) 9 (4) 0.995 10 (6)
Feeling lonely (intrapersonal) 20 (12) 6 (1) 16 (7) 0.420 10 (6)
Experienced little happiness with family/friends 22 (13) 12 (2) 7 (3) 0.616 8 (5)
Feeling of no longer being important to others 18 (11) 12 (2) 7 (3) 0.616 8 (5)
Feeling tired of life 17 (10) 12 (2) 7 (3) 0.996 9 (5)
Not satisfied with own self 12 (7) 6 (1) 7 (3) 0.995 7 (4)
Feelings of guilt 12 (7) 6 (1) 5 (2) 0.490 5 (3)
Lived a life with little purpose 8 (5) 6 (1) 2 (1) 0.997 3 (2)
Experienced little success in life 10 (6) 0 (0) 2 (1) 0.236 2 (1)
Domain IV: Environment
Relatives consider your suffering too severe 33 (19) 24 (4) 12 (5) 0..995 16 (9)
Practical loneliness (isolation, no one present for you) 15 (9) 12 (2) 12 (5) 0.995 12 (7)
Insufficient availability of care 12 (7) 12 (2) 7 (3) 0.616 8 (5)
Unsatisfactory social contacts 8 (5) 6 (1) 2 (1) 0.491 3 (2)
Insufficient support (family, relatives) 5 (3) 0 (0) 2 (1) 0.490 2 (1)
Shame 2 (1) 0 (0) 2 (1) 0.490 2 (1)
Domain V: Nature and prognosis of disease
Fear of future suffering 40 (24) 24 (4) 14 (6) 0.453 17 (10)
Fear of future failing strength to bear suffering 25 (15) 6 (1) 12 (5) 0.662 10 (6)
The SOS-V was missing in four patients.
Scoring: 1-not at all; 2-slightly; 3-moderately; 4-seriously; 5-very seriously, hardly could be worse.
Suffering bearable: scores 1–3 ; Suffering unbearable: scores 4,5.
Rounded percentages and absolute numbers.
*0 to 3 missing observations per symptom. Impaired working capacity applied for 10 persons (with work).
**Fisher’s exact tests.
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Table 5 Distribution of the qualitative data related to unbearable symptoms over categories of suffering in patients
with and without an explicit request for euthanasia (n = 60)
Explicit request (n = 17) No explicit request (n = 43)
Category of
suffering



















Physical suffering 76 (13) 3.0 (2.3) 72 (31) 2.8 (2.7) 0.752
Loss of meaning 88 (15) 2.6 (2.0) 65 (28) 2.4 (2.8) 0.843
Loss of autonomy 76 (13) 1.9 (1.9) 49 (21) 1.6 (1.1) 0.571
Loss of dignity 35 (6) 0.8 (1.9) 42 (18) 1.6 (2.0) 0.847
Experience to be a
burden to others
41 (7) 0.5 (0.7) 21 (9) 0.3 (0.5) 0.168
Loss of sexual role 0 (0) 0.0 (0.0) 5 (2) 0.05 (0.2) 0.374
Fear of future
suffering
18 (3) 0.2 (0.4) 14 (6) 0.3 (0.7) 0.644
Anxiety 6 (1) 0.1 (0.2) 19 (8) 0.3 (0.8) 0.078
Death anxiety 6 (1) 0.1 (0.5) 0 (0) 0.0 (0.0 0.332
Depressive thoughts 6 (1) 0.1 (0.2) 7 (3) 0.1 (0.3) 0.881
Worrying 6 (1) 0.1 (0.2) 19 (8) 0.2 (0.5) 0.087
Feeling tensed 6 (1) 0.1 (0.2) 7 (3) 0.1 (0.3) 0.881
Hopelessness 6 (1) 0.1 (0.2) 7 (3) 0.1 (0.3) 0.881
Pointlessness 6 (1) 0.2 (1.0) 5 (2) 0.1 (0.5) 0.548
The SOS-V was missing in four patients.
*Only equal ratings were used for analysis.
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primary care when initiating the procedure of compul-
sory criteria assessment to evaluate whether EAS is per-
mitted. How to interpret this finding as part of the
process in which physicians respond to requests for EAS
is unclear. Identified causes for not granting requests for
EAS included death of the patient before performance of
EAS (20%; percentage of total of ungranted requests),
death of the patient before finalization of decision mak-
ing (20%), withdrawal of the request by the patient (20%)
and refusal of the physician to comply to the request of
the patient (18%) [49].
Motives to request EAS may need to be interpreted
from a different perspective. A desire to control the cir-
cumstances of one’s death, rather than unbearable suffer-
ing due to loss of control, may determine the request for
EAS. Another driver of requests for EAS may be loss of
the will to continue living [56-58], caused by loss of
positive feelings towards life and (or) loss of connected-
ness with life [32,36,38,47,53,57]. Loss of energy and ex-
haustion, related to tiredness and weakness which are
prevalent among end-of-life cancer patients [29], may
contribute to loss of the desire to continue living. De-
pression and related suicidality in cancer patients are
possible causes of a request for EAS [59-61]. The preva-
lent role of depression related to requesting for EAS has
not been assessed in research [62,63]. Another perspectiveis that a genuine desire to die is absent in patients who ex-
press a wish to hasten death [22,64]. The underlying mes-
sage of a request for EAS might be a cry for help [22], a
request to be given a reason to live [37,64], or an expres-
sion of feelings [65]. None of these has been sufficiently
recognized or addressed. Finally societal influences need
to be considered. Individual choice is an important soci-
etal driver of Western society [66]. Practices which en-
hance autonomous choice in health care, e.g. physician
initiated discussions of the subject of EAS at an early stage
[67], or granting the wish of the patients as the motive to
provide EAS [13], may influence direction and outcomes
of provision of care [3,19,66,68,69]. The presence of an ad-
vance pro-euthanasia directive and higher education,
which occurred more frequently in patients with an expli-
cit request, may be in line with the perspective of control
and with the perspective of choice.
Patients depend upon responses of physicians. In
responding to patients with a request for EAS it needs
to be realized that dying cancer patients perceive that
they cannot feel completely independent, which affects
true autonomous decision making [70,71]. Additionally,
processes of transference may influence the communica-
tion between patient and physician. Awareness of such
processes is important when responding to patients with
a request for EAS [70,72,73]. Physician factors in re-
sponse to the suffering of patients include attitude and
Table 6 Patient characteristics and end-of-life trajectories in patients with an explicit euthanasia request (N=17)
Gender, age, tumor, euthanasia
directive
End of life Additional information provided by GP
Female, 76, colon, (+) Euthanasia Euthanasia in hospice by the GP; the patient did not want to
continue living after witnessing death of 26 others.
Female, 76, eye tumor, (+) Euthanasia Died in hospice; the GP performed euthanasia.
Male, 76, M. Kahler, (+) Euthanasia The GP performed euthanasia at home when patient became exhausted
after development of pneumonia.The GP stated: “the wish of the patient
was provided”.
Female, 55, colon, (+) Euthanasia Euthanasia performed in hospice in other town.
Male, 85, colon , (+) Physician assisted
suicide
Died at home, ingestion of barbiturates.
Female, 71, lung, (+) Terminal sedation The euthanasia procedure had been initiated, all compulsory criteria were
confirmed present, the final step towards EAS as yet was not set. The patient
was terminal, became drowsy, and changed her mind, expressing to a visiting
physician in out of regular hours care (during holidays) the wish to continue
living, and not to perform EAS. One day later, after deliberation, terminal
sedation was initiated. Then the family demanded euthanasia. The GP of the
patient considered to perform euthanasia. The consulting physician opposed
euthanasia, considering absent noticeable suffering. The patient died without
signs of suffering. The family remained dissatisfied.
Male, 69, mesothelioma Terminal sedation Died at home.
Male, 44, renal, (+) Terminal sedation Died at home.
Male, 84, lung, (+) Natural death No mention of persisting request; died at home
Female, 80, Grawitz, (+) Natural death A former nun who requested euthanasia when suffering increased.
The euthanasia procedure was initiated and all compulsory criteria were
assessed to be present. Ultimately the patient decided on religious
grounds not to continue the path of euthanasia and died at home.
Female, 79, esophagus, (+) Natural death No mention of persisting request; died at home.
Male, 78, lung, (+) Natural death No mention of persisting request; died in hospice cared for by the GP.
Female,78, colon Natural death No mention of persisting request; died in hospice cared for by the GP.
Male, 74, adenocarcinoma Natural death No mention of persisting request; died at home.
Male, 72, lung, (+) Natural death No mention of persisting request; died at home.
Female, 68, lung, (+) Natural death No mention of persisting request; died in hospice cared for by the GP.
Male, 66, lung Natural death No mention of persisting request; died at home.
(+): euthanasia directive present.
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interventions to reduce suffering in end-of-life cancer pa-
tients include symptom reduction [28], psycho-oncologic
interventions [32,33,36,47,75,76], spiritual care [77,78] and
palliative sedation [79,80]. A tradition of research investi-
gating effectiveness of palliative interventions in primary
care populations does not exist. Therefore little is known
about the effectiveness of interventions to reduce the suf-
fering of end-of-life cancer patients in this setting. Even
less is known about the question of which interventions
may reduce the prevalence of requests for EAS, or per-
formance of EAS. A remarkable quote in a Dutch qualita-
tive study was that some GPs, since adopting a more
caring attitude, found they no longer had to perform eu-
thanasia [74].
The present study has some limitations. The first is
the limited number of patients, which limits statistical
power. We cannot rule out the possibility of differencesin unbearable suffering between patients with and with-
out an explicit request that we did not find. Interviews
with most patients were not in the final days of life; un-
bearable suffering may have progressed, or may have
been adequately treated. Furthermore, for the patients
who explicitly requested euthanasia, the interview was
not administered at the time of the request. The sample
concerns a Western population in primary care in a con-
text of legally permitted EAS, which limits generalizability.
Conclusions
We conclude that in a population of end-of-life cancer
patients cared for in primary care no differences in un-
bearable suffering were found between patients with and
without explicit requests for EAS. The study raises the
question of whether unbearable suffering is the domin-
ant motive to request for EAS. Another outcome was
that most patients suffered from unbearable symptoms,
Ruijs et al. BMC Palliative Care 2014, 13:62 Page 10 of 11
http://www.biomedcentral.com/1472-684X/13/62indicating that the compulsory criterion of unbearable
suffering, part of the criteria which permit performing
EAS, may be met a priori in most end-of-life cancer pa-
tients dying at home, whether they request EAS or not.
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